Chemistry: molecular biology and microbiology – Process of utilizing an enzyme or micro-organism to destroy...
Reexamination Certificate
2006-10-31
2006-10-31
Witz, Jean C. (Department: 1651)
Chemistry: molecular biology and microbiology
Process of utilizing an enzyme or micro-organism to destroy...
C422S001000, C422S028000, C422S030000
Reexamination Certificate
active
07129080
ABSTRACT:
A proteinaceous material has been found to show similar activity and treatment response to that of disease causing prions, such as CJD. A prion model which incorporates the proteinaceous material has a variety of applications. The model has an ability to be cultured either in vivo or in vitro, allowing rapid screening of potential drugs for treating animals or humans, or methods of treating food products or items which may come into contact with prions, such as medical or dental devices. Several treatment methods and materials have been developed using the model.
REFERENCES:
patent: 3941696 (1976-03-01), Melnick et al.
patent: 4169123 (1979-09-01), Moore et al.
patent: 4473550 (1984-09-01), Rosenbaum et al.
patent: 4973449 (1990-11-01), Kolstad et al.
patent: 5007232 (1991-04-01), Caudill
patent: 5116575 (1992-05-01), Badertscher et al.
patent: 5145642 (1992-09-01), Feathers, III et al.
patent: 5173259 (1992-12-01), Bordini
patent: 5178841 (1993-01-01), Vokins et al.
patent: 5258162 (1993-11-01), Andersson et al.
patent: 5260021 (1993-11-01), Zeleznick
patent: 5567444 (1996-10-01), Hei et al.
patent: 5600142 (1997-02-01), Van Den Berg et al.
patent: 5634880 (1997-06-01), Feldman et al.
patent: 5674450 (1997-10-01), Lin et al.
patent: 5733503 (1998-03-01), Kowatsch et al.
patent: 5756678 (1998-05-01), Shenoy et al.
patent: 5779973 (1998-07-01), Edwards et al.
patent: 5788925 (1998-08-01), Pai et al.
patent: 5792435 (1998-08-01), Mueller et al.
patent: 5837193 (1998-11-01), Childers et al.
patent: 5848515 (1998-12-01), Catelli et al.
patent: 5872359 (1999-02-01), Stewart et al.
patent: 5876664 (1999-03-01), Childers et al.
patent: 6010994 (2000-01-01), Choy et al.
patent: 6094523 (2000-07-01), Zelina et al.
patent: 6162055 (2000-12-01), Montgomery et al.
patent: 6322802 (2001-11-01), Prusiner et al.
patent: 6387858 (2002-05-01), Shah et al.
patent: 6395506 (2002-05-01), Pitner et al.
patent: 6448062 (2002-09-01), Huth et al.
patent: 6488965 (2002-12-01), Karageozian
patent: 6503881 (2003-01-01), Krieger et al.
patent: 6660289 (2003-12-01), Wilmotte et al.
patent: 6696074 (2004-02-01), Dai et al.
patent: 6767712 (2004-07-01), Prusiner et al.
patent: 6875399 (2005-04-01), McVey
patent: 2003/0086820 (2003-05-01), McDonnell et al.
patent: 774 263 (1997-05-01), None
patent: 2759589 (1998-08-01), None
patent: 2814177 (2002-03-01), None
patent: 2391785 (2004-02-01), None
patent: WO 94/22305 (1994-10-01), None
patent: WO 98/15297 (1998-04-01), None
patent: WO/00 71575 (2000-11-01), None
patent: WO/01 00235 (2001-01-01), None
patent: WO 01/54736 (2001-08-01), None
Aguzzi et al. “Recent advances in prion biology” Current Opinions in Neurology (2004) 17: 337-342.
Denys et al. “Microbiocial efficacy of the STERIS EcoCycle 10 biohazardous waste destruction, decontamination and disposal system” Abstracts of the General Meeting of the American Society for Microbiology (1995) vol. 95, No. 0, pp. 445, abstract only.
Dyas et al. “Studies of novel agent possessing resistance to moist heat and disinfectants” parallels with Creutzfeldt-Jakob agent J. Hosp. Infection (1990) 15(3): 265-272□□.
Sklaviadis et al. “Physical properties of the Creutzfeldt-Jakob disease agent” J. Virol. 63(3): 1212-1222.
Ohlson, CWRU Magazine, Summer 2001, vol. 13, No. 4, pp. 22-24; “On the Trail of A Dread Disease”.
Burdon, J. Med. Microbiol, vol. 29 (1989), pp. 145-157; “A Novel Replicating Agent Isolated From the Human Intestinal Tract Having Characteristics Shared With Creutzfeldt-Jakob and Related Agents”.
Burdon, et al. J. Med. Microbiol, vol. 45 (1996), pp. 10-15; “Replication of IFDO On a Chemically Defined Medium”.
Burdon, The Lancet, vol. 353, Apr. 10, 1999; p. 1271; “Does Variant Creutzfeldt-Jakob Disease Have an Achilles Heel”?.
ASAIO Journal 2000, “Prion Disease and Medical Devices,” by Antloga, et al. Nov./Dec.
Burdon, et al., “Replication of IFDO on a Chemically Defined Medium”, Journ. Of Medical Microbiology, V. 45, N. 1, 1996, pp. 10-15 XP-002249888—(Abstract).
GMT Global Medical Technologies, Ltd. Product Information “Ecocycle 10” http://www.globalmedicaltechnologies.com/view—prd.php?code=bw0002 Sep. 15, 2005.
MSDS data sheet for the STERIS 20® Sterilant Concentrate.
Rutala, et al., “Creutzfeldt-Jakob Disease: Recommendations for Disinfection and Sterilization”, Clinical Infectious Diseases, V. 32, N. 9, May 2001, pp. 1348-1356 XP008012867.
Darbord, “Inactivation of Prions in Daily Medical Practice”, Biomedicine & Pharmacotherapy, V. 53, 1999, pp. 34-38 XP002228686.
Samson, “Stérilisation du materiel de dermato-chirurgie au cabinet du dermatologue” Nouvelle Dermatologiques, V. 19, N. 1, 2000 pp. 57-60 XP008012868.
Baron, et al., “Prions” in Disinfection, Sterilization and Preservation (Ed. S.S. Block); 5thEd. pp. 659-674, Lippincott, Williams & Williams, NY.
Disinfection, Sterilization and Preservation (Ed. S.S. Block); 4thEd. pp. 436-439 (Dec. 2000).
Yon, “Protein Folding: A Persepective for Biology, Medicine & Biotechnology”, Brazilian Journal of Medical & Biological Research (2001) 34: 419-435 ISSN 0100-879X.
Ernst, et al., “Comparative Analysis of Scrapie Agent Inactivation Methods”, Journal of Virological Methods, 41 (1993) 193-202 XP-002316603.
Brown, et al., “Effect of Chemicals, Heat and Histopathologic Processing on High-Infectivity Hamster-Adapted Scrapie Virus”, Journ. of Infectious Diseases, vol. 145, No. 5, May 1982 pp. 683-687.
Antloga Kathleen M.
McDonnell Gerald E.
Fay Sharpe Fagan Minnich & McKee LLP
Hanley Susan
Steris Inc.
Witz Jean C.
LandOfFree
Vitro model of priocidal activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vitro model of priocidal activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitro model of priocidal activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3638646